Caspase-8 and Tyrosine Kinases: A Dangerous Liaison in Cancer.

Caspase-8 NF-kB signaling cancer cell cycle tyrosine kinase

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
21 Jun 2023
Historique:
received: 26 05 2023
revised: 15 06 2023
accepted: 16 06 2023
medline: 14 7 2023
pubmed: 14 7 2023
entrez: 14 7 2023
Statut: epublish

Résumé

Caspase-8 is a cysteine-aspartic acid protease that has been identified as an initiator caspase that plays an essential role in the extrinsic apoptotic pathway. Evasion of apoptosis is a hallmark of cancer and Caspase-8 expression is silenced in some tumors, consistent with its central role in apoptosis. However, in the past years, several studies reported an increased expression of Caspase-8 levels in many tumors and consistently identified novel "non-canonical" non-apoptotic functions of Caspase-8 that overall promote cancer progression and sustain therapy resistance. These reports point to the ability of cancer cells to rewire Caspase-8 function in cancer and raise the question of which are the signaling pathways aberrantly activated in cancer that may contribute to the hijack of Caspase-8 activity. In this regard, tyrosine kinases are among the first oncogenes ever identified and genomic, transcriptomic and proteomic studies indeed show that they represent a class of signaling molecules constitutively activated in most of the tumors. Here, we aim to review and discuss the role of Caspase-8 in cancer and its interplay with Src and other tyrosine kinases.

Identifiants

pubmed: 37444381
pii: cancers15133271
doi: 10.3390/cancers15133271
pmc: PMC10340071
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Subventions

Organisme : Italian Association for Cancer Research
ID : AIRC-IG2021 n.26230

Références

Nat Med. 2000 May;6(5):529-35
pubmed: 10802708
Oncogene. 2016 Sep 1;35(35):4580-90
pubmed: 26829051
Mol Oncol. 2014 May;8(3):596-608
pubmed: 24484936
Int J Mol Sci. 2018 Nov 29;19(12):
pubmed: 30501030
Nat Rev Mol Cell Biol. 2014 Jul;15(7):433-52
pubmed: 24954208
Reprod Biol Endocrinol. 2019 Feb 13;17(1):23
pubmed: 30760288
Eur J Med Res. 2009;14:71-5
pubmed: 19258216
J Exp Med. 2004 Feb 16;199(4):449-58
pubmed: 14970175
EMBO J. 2006 May 3;25(9):1895-905
pubmed: 16619028
J Clin Invest. 2005 Feb;115(2):369-78
pubmed: 15650771
Mol Oncol. 2014 Oct;8(7):1220-30
pubmed: 24816188
Exp Cell Res. 2016 Sep 10;347(1):114-122
pubmed: 27432652
Nature. 2015 Jan 29;517(7536):576-82
pubmed: 25631445
J Leukoc Biol. 2021 Jan;109(1):121-141
pubmed: 32531842
Cancer Res. 2007 Dec 15;67(24):11505-9
pubmed: 18089778
J Biol Chem. 2002 Nov 22;277(47):45162-71
pubmed: 12215447
Gastroenterology. 2003 Sep;125(3):708-15
pubmed: 12949717
Cancers (Basel). 2011 Jun;3(2):1639-71
pubmed: 22348197
BMC Cancer. 2010 Feb 04;10:32
pubmed: 20132554
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
Carcinogenesis. 2004 May;25(5):661-8
pubmed: 14688019
Elife. 2017 Jun 08;6:
pubmed: 28594322
Protein J. 2017 Feb;36(1):1-6
pubmed: 28108801
Cancer Res. 2009 May 1;69(9):3755-63
pubmed: 19383910
J Biol Chem. 2007 Mar 9;282(10):7416-23
pubmed: 17213198
Cell Death Differ. 2023 Feb;30(2):417-428
pubmed: 36460775
FEBS J. 2018 Nov;285(22):4104-4123
pubmed: 29806737
Carcinogenesis. 2005 Dec;26(12):2086-94
pubmed: 16033771
Cancer Cell. 2010 Jan 19;17(1):98-110
pubmed: 20129251
Cancer Res. 2006 Apr 15;66(8):4273-8
pubmed: 16618751
J Biol Chem. 2008 Feb 29;283(9):5402-13
pubmed: 18086677
Blood. 2007 Feb 15;109(4):1442-50
pubmed: 17047155
Cell Death Differ. 2010 Apr;17(4):710-8
pubmed: 19851329
Oncogene. 2006 Aug 28;25(38):5220-7
pubmed: 16936740
Oncogene. 2016 Oct 27;35(43):5629-5640
pubmed: 27109099
Mol Cell. 2019 Feb 7;73(3):413-428.e7
pubmed: 30598363
Biochem J. 2004 Sep 1;382(Pt 2):651-7
pubmed: 15209560
Cold Spring Harb Perspect Biol. 2013 Jun 01;5(6):
pubmed: 23732469
Mol Cell. 2020 Mar 5;77(5):970-984.e7
pubmed: 31982308
Oncogene. 2021 Jun;40(22):3775-3785
pubmed: 33972681
Oncogene. 2009 Sep 3;28(35):3097-110
pubmed: 19597472
Cancers (Basel). 2020 Jun 12;12(6):
pubmed: 32545574
Trends Genet. 2008 Sep;24(9):457-66
pubmed: 18675487
Mol Cell. 2017 Feb 16;65(4):715-729.e5
pubmed: 28212752
J Biol Chem. 2009 Dec 4;284(49):34342-54
pubmed: 19833726
BMC Cancer. 2013 Nov 09;13:532
pubmed: 24209510
Free Radic Biol Med. 2022 Nov 1;192:51-62
pubmed: 36165926
Cell Death Differ. 2017 Aug;24(8):1359-1368
pubmed: 28338655
Cancer Discov. 2012 May;2(5):401-4
pubmed: 22588877
Cancer Res. 2009 Jun 15;69(12):5023-9
pubmed: 19470771
Immun Inflamm Dis. 2016 Jul 21;4(3):327-37
pubmed: 27621815
Trends Pharmacol Sci. 2012 Mar;33(3):122-8
pubmed: 22153719
Genes Dev. 2003 Apr 1;17(7):883-95
pubmed: 12654726
JCI Insight. 2020 Dec 3;5(23):
pubmed: 33108350
Cancer Metastasis Rev. 2021 Mar;40(1):303-318
pubmed: 33026575
Int J Oncol. 2016 Jun;48(6):2339-48
pubmed: 27082853
Nature. 2006 Jan 5;439(7072):95-9
pubmed: 16397500
BMC Cancer. 2012 Jun 06;12:218
pubmed: 22672670
J Biol Chem. 2011 Mar 4;286(9):6946-54
pubmed: 21183680
Clin Cancer Res. 2011 Oct 15;17(20):6459-66
pubmed: 22003073
Biochim Biophys Acta Rev Cancer. 2020 Apr;1873(2):188357
pubmed: 32147543
Mol Biol Cell. 2010 Jan 15;21(2):369-76
pubmed: 19923319
Biochem J. 2004 Sep 1;382(Pt 2):e1-3
pubmed: 15317488
Cancer Res. 2005 Feb 1;65(3):815-21
pubmed: 15705878
Semin Cell Dev Biol. 2018 Oct;82:105-117
pubmed: 29410361
Cancer Res. 2002 Oct 15;62(20):5897-901
pubmed: 12384554
Cold Spring Harb Perspect Biol. 2020 Jun 1;12(6):
pubmed: 31727679
Cell Death Dis. 2021 Aug 6;12(8):775
pubmed: 34362880
Curr Biol. 2006 Aug 22;16(16):1666-71
pubmed: 16920630
Cell Death Differ. 2003 Jan;10(1):144-5
pubmed: 12655304
Biochem Pharmacol. 2008 Dec 1;76(11):1365-73
pubmed: 18761323
EMBO J. 2003 Aug 15;22(16):4132-42
pubmed: 12912912
Transl Oncol. 2010 Feb;3(1):1-12
pubmed: 20165689
PLoS One. 2016 Apr 21;11(4):e0153946
pubmed: 27101103
Mol Cancer. 2018 Feb 19;17(1):58
pubmed: 29455648
Science. 2005 Mar 4;307(5714):1465-8
pubmed: 15746428
Oncogene. 2005 Aug 25;24(36):5619-28
pubmed: 16044164
Mol Cell. 2007 Apr 27;26(2):301-10
pubmed: 17466630
EMBO J. 1996 Dec 16;15(24):6969-78
pubmed: 9003773
Cell Death Differ. 2019 Jan;26(2):199-212
pubmed: 30538286
Sci Signal. 2013 Apr 02;6(269):pl1
pubmed: 23550210
Neurosci Res. 1991 Sep;11(4):229-60
pubmed: 1661875
Cell. 1996 Jun 14;85(6):817-27
pubmed: 8681377
Trends Cell Biol. 2017 May;27(5):322-339
pubmed: 28188028
Cancer Cell. 2017 Sep 11;32(3):342-359.e10
pubmed: 28898696
Oncogene. 2000 Sep 14;19(39):4451-60
pubmed: 11002417
Cell Res. 2016 Aug;26(8):914-34
pubmed: 27325299
J Immunol. 2007 Oct 15;179(8):5291-300
pubmed: 17911615
Mol Cell Biol. 2010 Dec;30(24):5726-40
pubmed: 20937773
Cold Spring Harb Perspect Biol. 2010 Sep;2(9):a001222
pubmed: 20463003
Cancer Lett. 2013 May 28;332(2):133-40
pubmed: 20817393
J Biol Chem. 2008 May 9;283(19):13031-4
pubmed: 18216014
Curr Mol Med. 2014 Feb;14(2):246-54
pubmed: 24467204

Auteurs

Claudia Contadini (C)

Laboratory of Cell Signaling, IRCCS-Fondazione Santa Lucia, 00179 Rome, Italy.
Department of Biology, University of Rome "Tor Vergata", 00133 Rome, Italy.

Alessandra Ferri (A)

Department of Pathology and Laboratory Medicine, New York Presbyterian Hospital, Weill Cornell Medicine, New York, NY 10021, USA.

Claudia Cirotti (C)

Laboratory of Cell Signaling, IRCCS-Fondazione Santa Lucia, 00179 Rome, Italy.
Department of Biology, University of Rome "Tor Vergata", 00133 Rome, Italy.

Dwayne Stupack (D)

Moores Cancer Center, University of California San Diego, 3855 Health Sciences Drive, La Jolla, CA 92093-0803, USA.

Daniela Barilà (D)

Laboratory of Cell Signaling, IRCCS-Fondazione Santa Lucia, 00179 Rome, Italy.
Department of Biology, University of Rome "Tor Vergata", 00133 Rome, Italy.

Classifications MeSH